Objective:Hepatocellular carcinoma (primary liver cancer, PLC) is one of common malignanttumors, the mortality rate among the malignant tumor is the second in China .The currenttreatment of the PLC is surgery, however, the literature indicated that liver cancer recurrence ratewas 57%-81% after 3 years, which severely threaten the lives and health of the people. So thesearch for effective inhibition of invasion and metastasis and recurrence of liver cancer researchbecame the key and difficult. Xiaoaiping com...